(3) The name and address of the supplier from whom the controlled substances are being ordered must be entered on the form. Triplicate DEA Forms 222 for carfentanil, etorphine hydrochloride, and diprenorphine must contain only these substances. The number of lines completed must be noted on that form at the bottom of the form, in the space provided. An item must consist of one or more commercial or bulk containers of the same finished or bulk form and quantity of the same substance. (2) Only one item may be entered on each numbered line. Triplicate DEA Form 222 must be prepared by use of a typewriter, pen, or indelible pencil. (1) A purchaser must prepare and execute a triplicate DEA Form 222 simultaneously by means of interleaved carbon sheets that are part of the triplicate DEA Form 222. (b) Procedure for executing triplicate DEA Forms 222. Triplicate DEA Forms 222 will not be accepted after October 30, 2021. The DEA will no longer issue triplicate forms. (a) Procedure for obtaining triplicate DEA Forms 222. The provisions of this part are applicable to the use of triplicate forms, except for the specific rules as provided in this section.
In any case, as soon as a registrant's supply of triplicate DEA Forms 222 is exhausted, the registrant must use the new single-sheet DEA Form 222.
Registrants may continue to use existing stocks of the triplicate DEA Form 222 until October 30, 2021.
§ 1305.20 Transition provisions allowing continued use of existing stocks of triplicate DEA Forms 222.
0 kommentar(er)
